Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of VCT220 Tablets in Overweight or Obese Participants
NCT06939296 is registered in ClinicalTrials.gov with Vincentage Pharma Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of VCT220 Tablets in Overweight or Obese Participants
- Lead sponsor
- Vincentage Pharma Co., Ltd
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 24, 2024
- Completion date
- March 31, 2026
- Enrollment
- 840 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.